A feasibility study of smokeless moxibustion for pregnant women in breech presentation at home: Using online
Not Applicable
Recruiting
- Conditions
- Pregnant women with a singleton breech presentation between 32 and 35 weeks of gestation.
- Registration Number
- JPRN-UMIN000046134
- Lead Sponsor
- Saitama Prefectural University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.Complications: maternal heart or kidney disease. 2.Obstetric complications: pregnancy with multiples of twins and beyond, risk of preterm birth (preterm uterine contractions, initial dilatation, or shortening of the cervix with a score of 4 on the Bishop scale; tocolytic therapy), uterine fibroids > 4 cm, placenta previa, hypertensive disorders of pregnancy, premature rupture of membranes. 3.Contraindication to vaginal delivery: previous uterine surgery, uterine malformations, bone pelvic defects. 4.Fetal conditions: intrauterine growth restriction, fetal malformation, or chromosomal disorder. 5.Conditions to avoid in interventions: prior moxibustion treatment to achieve fetal version.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility Implementation 1.Number of women who were able to implement the protocol as per the protocol. 2.Number of days and number of times each moxibustion could be performed according to the protocol.
- Secondary Outcome Measures
Name Time Method Practicality 1.Side effects of intervention. Feelings of unpleasantness, nausea, vomiting, uterine contraction, burns, and levels with burns. 2.How pregnant women feel about the "smell" of moxibustion. 3.Burden of implementing moxibustion 4.Changes in physical symptoms after the implementation of moxibustion Acceptability 1.satisfaction 2.Families' understanding of moxibustion implementation. 3.Evaluation of explanation methods, materials used, and explanations using a web conference tool. Obstetric-gynecological variables (parity, gestational age at the start of treatment, height (cm), weight (kg), employment status, and sensitivity to cold, fetal presentation after 10-14 days from commencement of the intervention)